Study of Human IgG and IgE Antibodies Against Bee (Apis mellifera) Venom (original) (raw)
IgE and T-cell responses to high-molecular weight allergens from bee venom
Hugues Henry
Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, 1999
View PDFchevron_right
Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings
John Deighton
Clinical & Experimental Allergy, 1993
View PDFchevron_right
Systemic and local reactions of bee venom immunotherapy in Iran
Zahra Pourpak
Iranian journal of allergy, asthma, and immunology, 2007
View PDFchevron_right
Comparison of the allergenic properties of bee venom and whole bee body extract
Nelson A Rosário
Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, 1976
View PDFchevron_right
Bees and Wasps Venom Toxins, Its Immune-Allergic Responses, Diagnosis and Therapeutics
Ravi Kant Upadhyay
International Journal of Pharmacy and Pharmaceutical Sciences, 2021
View PDFchevron_right
Characteristics of venom allergic reactions in Turkish beekeepers and alternative treatment modalities
Ali Korkmaz
International Forum of Allergy & Rhinology, 2014
View PDFchevron_right
Triple IgE-positivity to hornet, wasp and bee venom in the patient with anaphylaxis: Diagnostic and therapeutic approach
Sladjana Andrejevic
Vojnosanitetski pregled
View PDFchevron_right
Double positivity to bee and wasp venom: Improved diagnostic procedure by recombinant allergen–based IgE testing and basophil activation test including data about cross-reactive carbohydrate determinants
Bernadette Eberlein
Journal of Allergy and Clinical Immunology, 2012
View PDFchevron_right
Time course of serum inhibitory activity for facilitated allergen-IgE binding during bee venom immunotherapy in children
Maximilian ZACH
Clinical & Experimental Allergy, 2009
View PDFchevron_right
Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy
Marcel G Frick
Journal of Allergy and Clinical Immunology, 2016
View PDFchevron_right
Production of Human Antibodies to Bee Venom Phospholipase A2 in Vitro
Christoph Heusser
Scandinavian Journal of Immunology, 1989
View PDFchevron_right
Antibody binding to venom carbohydrates is a frequent cause for double positivity to honeybee and yellow jacket venom in patients with stinging-insect allergy
Iain Wilson, Stefan Wöhrl
Journal of Allergy and Clinical Immunology, 2001
View PDFchevron_right
Natural Honey Bee venom Manipulates Human Immune Response
Mostafa Hassan
The Egyptian Journal of Hospital Medicine, 2018
View PDFchevron_right
Allergy to Bee Venom in Beekeepers in Germany
Richard von Georgi
2008
View PDFchevron_right
Insect venom allergy: a prospective case study showing lack of correlation between immunologic reactivity and clinical sensitivity
J. Doerr
Journal of Allergy and Clinical Immunology, 1981
View PDFchevron_right
Bee venom phospholipase A2‐specific T cell clones from human allergic and non‐allergic individuals: cytokine patterns change in response to the antigen concentration
José Carballido
European Journal of Immunology, 1992
View PDFchevron_right
Regulation of IgE and IgG responses by allergen specific T-cell clones to bee venom phospholipase A in vitro
Christoph Heusser
Journal of Allergy and Clinical Immunology, 1994
View PDFchevron_right
High-dose bee venom exposure induces similar tolerogenic B cell responses in patients and healthy beekeepers
Anna Bodzenta-lukaszyk
Allergy, 2016
View PDFchevron_right
Comparable profiles of serum histamine and IgG4 levels in allergic beekeepers
CATERINA CHLIVA
Allergy, 2015
View PDFchevron_right
Api m 6: A new bee venom allergen
Alexander Kettner
Journal of Allergy and Clinical Immunology, 2001
View PDFchevron_right
IgE recognition of chimeric isoforms of the honeybee (Apis mellifera) venom allergen Api m 10 evaluated by protein array technology
Thilo Jakob, Simon Blank
Molecular Immunology, 2015
View PDFchevron_right
Laboratory markers of mast cell and basophil activation in monitoring rush immunotherapy in bee venom-allergic children
Radoslaw Spiewak
Immunotherapy, 2011
View PDFchevron_right
Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy
Akos Heinemann
Allergy, 2007
View PDFchevron_right
Induction and differential regulation of bee venom phospholipase A2–specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells☆, ☆☆, ★, ★★
Christoph Heusser
Journal of Allergy and Clinical Immunology, 1997
View PDFchevron_right
Antigen-independent suppression of the IgE immune response to bee venom phospholipase A2 by maternally derived monoclonal IgG antibodies
Lee Shaw
European Journal of Immunology, 1998
View PDFchevron_right
In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy
Johannes Ring
Journal of investigational allergology & clinical immunology, 2006
View PDFchevron_right
In vitroBiphasic Effect of Honey Bee Venom on Basophils from Screened Healthy Blood Donors
Salvatore Chirumbolo
View PDFchevron_right
Diagnosis of Apis dorsata venom allergy: use of recombinant allergens of Apis mellifera and a passive basophil activation test
Peshala Gunasekara
Clinical and Molecular Allergy
View PDFchevron_right
The role of bee venom on immunological and hematological parameters in albino rats
Ahmed Ismail
Egyptian journal of Immunology
View PDFchevron_right
An HLA-associated nonresponsiveness to melittin: A components of bee venom+
Penny Lympany
Journal of Allergy and Clinical Immunology, 1990
View PDFchevron_right
Anaphylactic Reaction to Bee Stings in the Rural Areas of Gorgan City: Iran’s First Epidemiological Study of Hymenoptera-Induced Anaphylaxis
Mehdi Torabizadeh, Seyed ali Aghapour
Journal of Pediatrics Review
View PDFchevron_right